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ABSTRACT
Objective: To investigate the feasibility of conducting
clinics for chronic fatigue syndrome/myalgic
encephalomyelitis (CFS/ME) in schools.
Design: School-based clinical project.
Participants: Children aged 11e16 years were
enrolled in three state secondary schools in England.
Main outcome measures: Number of children newly
diagnosed as having CFS/ME.
Methods: Attendance ofﬁcers identiﬁed children
missing $20% of school in a 6-week term without
a known cause, excluding those with a single episode
off school, a known medical illness explaining the
absence or known to be truanting. Children with
fatigue were referred to a specialist CFS/ME service for
further assessment. The authors compared children
with CFS/ME identiﬁed through school-based clinics
with those referred via health services. Outcomes of
CFS/ME were evaluated at 6 weeks and 6 months.
Results: 461 of the 2855 enrolled children had missed
$20% school over a 6-week period. In 315, of whom
three had CFS/ME, the reason for absence was known.
112 of the 146 children with unexplained absence
attended clinical review at school; two had been
previously diagnosed as having CFS/ME and 42 were
referred on to a specialist clinic, where 23 were newly
diagnosed as having CFS/ME. Therefore, 28 of the
2855 (1.0%) children had CFS/ME. Children with CFS/
ME identiﬁed through surveillance had been ill for an
amount of time comparable to those referred via health
services but had less fatigue (mean difference 4.4,
95% CI 2.2 to 6.6), less disability (mean difference
 5.7, 95% CI  7.9 to  3.5) and fewer symptoms
(mean difference 1.86, 95% CI 0.8 to 2.93). Of 19
children followed up, six had fully recovered at
6 weeks and a further six at 6 months.
Conclusions: Chronic fatigue is an important cause
of unexplained absence from school. Children
diagnosed through school-based clinics are less
severely affected than those referred to specialist
services and appear to make rapid progress when they
access treatment.
INTRODUCTION
Estimates of the prevalence of paediatric
chronic fatigue syndrome/myalgic encepha-
lomyelitis (CFS/ME) show considerable vari-
ation according to survey methodology and
diagnostic criteria. A postal survey of 1024
UK general practices (GPs) estimated the
prevalence using the Royal College of
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ARTICLE SUMMARY
Article focus
- Hypothesis: many children with CFS/ME remain
undiagnosed and untreated, despite evidence
that treatment is effective in children.
- Research question: are school-based clinics
a feasible way to identify children with CFS/ME
and offer treatment?
Key messages
- 1.0% of enrolled children missed $20% of
school because of CFS/ME.
- Fewer than one in ﬁve children with CFS/ME had
received a diagnosis and been offered treatment.
- Children with CFS/ME who were detected
through school-based clinics were less severely
affected than children referred via health services
and appeared to do well once treated.
Strengths and limitations of this study
- Children were offered assessment regardless of
how their absence had been classiﬁed.
- All children given a diagnosis of CFS/ME were
screened for other medical and emotional causes
of fatigue and were prospectively characterised
and followed up.
- School clinics were conducted in three schools in
the south west, which has a well-established
specialist CFS/ME service. Results may not be
generalisable to regions without a CFS/ME
service or to regions with different socioeco-
nomic factors that impact on school attendance.
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1 to be only
0.06% in children aged 5e19 years,
2 while population-
based surveys suggest that the prevalence is between
0.1% and 0.5%.
3e5 These differences could be due to
difﬁculties in diagnosis, non-attendance at medical
services or differences in the type of CFS/ME identiﬁed
by GPs compared with the spectrum of the condition in
the childhood population. Only 52% of GPs feel conﬁ-
dent in making the diagnosis in adults,
6 let alone
children. It is therefore likely that many children with
CFS/ME remain undiagnosed and untreated, despite
evidence that treatment is effective in children.
7e11
In this paper, we report results from a school-based
clinical project to assess children missing school in order
to identify undiagnosed CFS/ME, and hence improve
access to a paediatric CFS/ME service.
METHODS
This study reports on a pilot clinical service set up with
the school attendance service in Bath to try and improve
school attendance. The service was offered in three state
secondary schools (two mixed gender and one girls
only) that were actively working to improve attendance.
The attendance ofﬁcer in each school identiﬁed all
children in years 7e11 (ages 11e16 years) who had
missed $20% of school over a 6-week term. Children
were excluded if they only had a single episode of
absence (eg, a 2-week illness), a medical illness that
could reasonably explain the absence, a known hospital
admission or were known to have been on holiday or to
be truanting. Families of the remaining children were
sent a letter from the school that invited them to meet
with a paediatrician from the Bath specialist CFS/ME
team (EMC) and a member of school staff to discuss why
their child was missing school.
Diagnosis and management of CFS/ME
Children identiﬁed in school clinics as having fatigue
were invited to attend the Bath specialist CFS/ME
service
12 at the Royal National Hospital for Rheumatic
Diseases for assessment. The Bath specialist paediatric
CFS/ME service covers a region in the south west of
England with a population of some 400000 children
aged 5e19 years (2001 census) and accepts referrals
from schools, GPs and paediatricians. Each year, >200
children and young people are assessed and treated
following NICE guidance
13 in outpatient clinics unless
they are too severely affected to attend clinic, in which
case they are seen at home. The following self-completed
inventories were collected prior to assessment, at 6 weeks
and 6 months: the 11-question Chalder fatigue scale
14;
the 10-question physical function subscale of the SF36
15
(a well-validated health survey questionnaire where the
worst physical function scored 10 and good physical
function scored 30), a visual analogue pain scale; the
Spence Children’s Anxiety Scale
16 and the Hospital
Anxiety and Depression Scale.
17 School attendance was
recorded at the time of assessment using a single-item
inventory.
Inventories were coded as missing if >1 question was
missing, apart from the Spence Children’s Anxiety Scale,
which was coded as missing when there were >2 missing
items. On the Hospital Anxiety and Depression Scale,
each seven-item subscale was excluded if there was more
than one question missing. Questions for which two
answers were given were coded as missing. Total scores
were corrected for the number of missing items.
Children who attended the specialist service had a full
paediatric assessment including a medical history,
examination and screening blood tests as recommended
in NICE guidelines
13 to exclude other causes of fatigue.
A diagnosis of CFS/ME was given using diagnostic
criteria recommended in NICE guidelines
13 to children
who had disabling fatigue lasting 3 months or longer
with one additional symptom, where no other cause for
the fatigue could be established.
Children with CFS/ME were offered specialist medical
care, following NICE guidance,
13 by the CFS/ME
specialist service. All children who accessed the specialist
service received advice and help with sleep and activity
management. Some children received cognitivee
behavioural therapy, while others received graded exer-
cise therapy.
13 We used school attendance at 6 months,
ascertained through follow-up questionnaires and by
review of medical notes, as our primary outcome.
Statistical methods
We derived exact binomial CIs for proportions. We
compared characteristics of children diagnosed as
having CFS/ME through the school surveillance
programme with those referred via health services using
unpaired t tests. Gender between the two groups was
compared using the c
2 test.
RESULTS
Identiﬁcation of children with fatigue
The project was carried out over three school terms
between 3 September 2007 and 15 February 2008 for
school 1 and over two terms between 31 October 2007
and 15 February 2008 for schools 2 and 3. The school
rolls for children in years 7e11 at the time of the study
were 925, 1055 and 875 children, respectively (total
2855).
Figure 1 shows the ﬂow of children through the study.
A total of 461 (16.1%) children were reported to have
missed $20% of school over a 6-week period during one
or more terms. Of these, 315 (68.3%) had only a single
episode off school, had a known medical illness that
could explain the absence (three of these had CFS/ME
and were being seen by the specialist CFS/ME service)
or were known to have been on holiday or to have been
truanting. The remaining 146 children (5.1% of school
roll) had missed $20% school without an identiﬁable
cause and were invited to a clinical review at school. Of
these, 112 (76.7%) attended the school clinic.
Forty-eight children (42.9% of those assessed and
2.1% of the school roll) described signiﬁcant fatigue as
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ments for more detailed assessments at the specialist
service. Of the remaining 64 children assessed, 30 had
medical problems that explained their absence. These
included recurrent headaches/migraines in nine chil-
dren, infections (eg, tonsillitis, diarrhoea and vomiting
or viral upper respiratory tract infections) in eight chil-
dren, 24 children were missing school because of social
or emotional problems, eight because they were
truanting and two had a diagnosis of CFS/ME conﬁrmed
by a paediatrician but had not been referred to the
specialist service.
Forty-one children with fatigue attended further
outpatient assessment by the specialist service, while one
child was severely affected so was assessed at home. Of
these, 23 were diagnosed as having CFS/ME that was
thought to be the main reason for their reduced school
attendance and were offered rehabilitation. Of the 19
children assessed but not diagnosed as having CFS/ME,
14 had fatigue secondary to mood disorders (mostly
anxiety and depression). Of these, 11 were referred to
local Child and Adolescent Mental Health Services. Five
children had other medical problems that were thought
to be the cause of their fatigue (sleep apnoea (two),
recurrent tonsillitis (one), migraine (one) and undiag-
nosed sleep disorder not CFS/ME (one)).
In summary, a total of 28 children (6.1% of the 461
children who were missing $20% of school) had CFS/
ME. These included 23 (82.1%) new cases of CFS/ME
identiﬁed through school clinics, and two (7.1%) chil-
dren identiﬁed as having CFS/ME previously diagnosed
by a paediatrician but not known to the school or to the
specialist service. Only three (10.7%) children with CFS/
ME were already being seen by the CFS/ME service and
so were not offered further assessment. The estimated
prevalence of CFS/ME sufﬁciently severe to cause a child
to miss $20% of school was 28/2855¼0.98% (95% CI
0.65% to 1.41%). This is likely to be an underestimate
as some of the 39 children who were invited to but
did not attend school clinics were likely to have had
CFS/ME.
Comparison of children with CFS/ME identiﬁed through
school with those referred by health services
Table 1 compares the characteristics of the 23 children
identiﬁed as having CFS/ME through school surveil-
lance and who attended the specialist service with those
of 604 children with CFS/ME referred to the specialist
service by a health professional. Children identiﬁed
through surveillance were less fatigued, had less pain,
had fewer symptoms and were less physically disabled
than those referred to the specialist service. However, the
length of time for which children had been unwell
(mean 20.2 months, SD 17.1) was comparable. There
was little evidence that levels of anxiety and depression
differed between the two groups.
Figure 1 Flow of children
through study. *Attendance <80%
for at least 6 weeks in any term
over three terms. CFS/ME,
chronic fatigue syndrome.
School roll (n=2855)
Attendance* <80% (n=461)
Unexplained absence (n=146)
Attended school clinic (n=112)
Truancy 
(n=8)
Social or 
emotional
(n=24)
Significant fatigue so
invited to CFS/ME clinic 
(n=48)
Medical 
cause 
(n=30)
Known CFS/ME not 
already referred to 
clinic (n=2)
Attended CFS/ME 
assessment (n=42)
Other medical 
(n=5)
Mood disorder 
(n=14)
New CFS/ME 
(n=23)
Reason for absence 
known (n=315, of 
whom n=3 known to 
have CFS/ME)
Did not attend (n=34)
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school
Of the 23 children diagnosed as having CFS/ME, four
were given advice about managing CFS/ME but did not
attend follow-up appointments or return follow-up
inventories. Of the remaining 19 children, 12 (63.2%)
were attending full-time school by 6 months, of whom six
had made a full recovery and were attending full-time
school with minimal advice after 6 weeks. One house-
bound child improved and was attending school part
time every day by 3 months. For the remaining six chil-
dren, school attendance did not alter signiﬁcantly at
6 months.
DISCUSSION
In school-based clinics, 28 of the 2855 (0.98%) children
aged 11e16 years were missing $20% of school and were
diagnosed as having CFS/ME. Of these, only 3 of 28
(10.7%) had received a diagnosis and accessed specialist
treatment. The duration of symptoms in those identiﬁed
through clinics was comparable to those referred to via
health services, but they were not as severely affected.
Outcomes following treatment were encouraging.
There are several possible reasons why children
missing signiﬁcant amounts of school with CFS/ME are
not identiﬁed. Those with mild or moderate CFS/ME
may not see their GP or may not be recognised as having
CFS/ME if they are seen. Alternatively, GPs and paedia-
tricians may not be aware of specialist CFS/ME services
or may feel that the child’s CFS/ME is not sufﬁciently
serious to warrant a referral. Children referred to the
Bath specialist CFS/ME service are more severely
affected than those described by other specialist
services.
12 Differences in characteristics at referral did
not appear to be explained by the length of time from
symptom onset or co-morbid mood problems.
Strengths and weaknesses
Children were offered assessment regardless of whether
their absence had been classiﬁed as ‘authorised’ or
‘unauthorised’. This is because fatigue that is causing
a child to miss school may have been ascribed to social or
educational problems, leading their absence to be clas-
siﬁed as unauthorised. All children given a diagnosis
of CFS/ME had been screened for other medical
and emotional causes of fatigue, were prospectively
characterised and followed up with well-validated
inventories.
Our clinics were conducted in three schools in one city
in the south west of England in which there is already
a well-established specialist CFS/ME service. The preva-
lence of CFS/ME, and reasons for school absence, may
be different in regions where there is no specialist
service and may vary according to the prevalence of
socioeconomic factors that impact on school attendance.
One of the schools was a girls-only school. A cross-
sectional study of British children found little evidence
that female gender was a risk factor for CFS/ME diag-
nosed using the Centers for Disease Control and
Prevention criteria or parental report,
3 although adult
CFS/ME is more common in women than in men.
18 If
the prevalence of CFS/ME was higher in girls than in
boys aged 11e16 years, then we would have over-
estimated the overall prevalence. We were not able to
obtain information on children who did not attend the
specialist service for assessment.
Results in context with previous literature
The prevalence of diagnosed CFS/ME in this study (3/
2855¼0.11%) is similar to the prevalence of 0.07%
reported in two other school surveys
19 and the preva-
lence of CFS/ME diagnosed in primary care (0.06%).
2
We identiﬁed more children with CFS/ME than a recent
British study, which identiﬁed chronic fatigue syndrome
in only seven of 8839 children enrolled in 10 schools.
20
However, that study screened children who missed 20%
of school and whose absence was recorded as ‘medical
absence’, whereas we assessed children who missed
school for any reason, including those whose absence
Table 1 Characteristics of children with CFS/ME identiﬁed through school project (school CFS/ME) compared with those with
CFS/ME referred to a specialist CFS/ME service (service CFS/ME)
School CFS/ME Service CFS/ME Mean difference
(95% CI) p Value NN
Age (years), mean (SD) 23 14.6 (1.5) 604 14.3 (2.8)  0.38 ( 1.5 to 0.8) 0.53
Female, n (%) 23 17 (74) 607 422 (69.5) 0.20
Fatigue score, mean (SD) 22 20 (5.7) 541 24.4 (5.1) 4.4 (2.2 to 6.6) <0.001
Pain score, mean (SD) 16 37.4 (29.4) 503 46.9 (29.7) 9.5 ( 5.3 to 24.3) 0.21
SF36, mean (SD) 22 25.5 (3.9) 526 19.8 (5.2)  5.7 ( 7.9 to  3.5) <0.001
Number of symptoms, mean (SD) 22 6.6 (2.2) 582 8.5 (2.5) 1.86 (0.80 to 2.93) <0.001
Depression (HADS), mean (SD) 23 6.7 (2.2) 399 7.3 (3.7) 0.6 ( 0.9 to 2.16) 0.43
Anxiety (HADS), mean (SD) 23 9.4 (4.0) 400 8.4 (4.3)  1.0 ( 2.8 to 0.78) 0.27
Anxiety (SCAS), mean (SD) 22 35.2 (20.1) 471 29.3 (17.8)  6.0 ( 13.6 to 1.7) 0.13
% School attendance, mean (SD) 23 65.9 (28.7) 569 38.6 (36.1)  27.3 ( 42.6 to  12.01) <0.001
Time to assessment (months), mean (SD) 21 22.5 (18.3) 590 25.3 (25.3) 2.7 ( 8.2 to 13.7) 0.62
CFS/ME, chronic fatigue syndrome; HADS, Hospital Anxiety and Depression Scale; SCAS, Spence Children’s Anxiety Scale.
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was also higher than estimates of between 0.1% and
0.5% from population-based studies,
3e5 perhaps because
these used the adult deﬁnition of CFS/ME, which
requires 6 months of fatigue and four additional symp-
toms. Our prevalence estimate is lower than that of 2.3%
for CFS/ME with 3-month duration, from a study in
twins.
21
Implications
Surveillance is particularly important for diseases, such
as CFS/ME, where there may be poor parental recogni-
tion of symptoms and presentation for assessment.
22
This project suggests that undiagnosed CFS/ME can be
identiﬁed through school-based clinics and may be an
important and underappreciated cause of school
absence in children aged 11e16 years. We also identiﬁed
potential medical or psychological causes of fatigue in
children who were not diagnosed as having CFS/ME.
Although we do not have outcome data for these chil-
dren, the identiﬁcation of a potential cause is likely to be
of beneﬁt in this group. Reduced school attendance is
associated with worse educational attainment and may
increase the risk of unemployment.
23
Surveillance can be justiﬁed when improved outcomes
in those identiﬁed and treated outweigh both harms and
costs. NICE guidelines
13 recommend that even those
children who have mild CFS/ME should be referred to
a specialist CFS/ME service after 6 months. There is
some evidence that particular treatments (graded exer-
cise therapy and cognitiveebehavioural therapy) are
moderately effective in children,
8e11 while the recently
reported PACE trial provided strong evidence that these
treatments are moderately effective in adults.
24 Large-
scale randomised controlled trials are needed in chil-
dren; however, our ﬁnding that more than half (12/23)
of children with school-clinic-diagnosed CFS/ME
returned to full-time school within 6 months of the start
of treatment compares well with results from other
follow-up studies,
25 suggesting that offering specialist
services to children with CFS/ME identiﬁed through
surveillance may reduce school absence. Nonetheless, it
would be of interest to evaluate whether school nurses,
rather than doctors, can undertake the initial assess-
ments in school clinics and to conduct randomised
controlled trials evaluating the effectiveness and cost-
effectiveness of school-based surveillance programmes
for CFS/ME. Further studies are needed to investigate
the potential for harm in offering surveillance for
fatigue to children who do not have a medical diagnosis
to explain their absence from school.
In conclusion, school-based clinics are feasible and
have the potential to identify children with CFS/ME,
which may reduce school absence and its harmful
consequences. Together with referral to specialist
services, school-based clinics have the potential to
improve overall school attendance.
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